MedTech & Diagnostics

Masimo Executive Compensation (FY25)

MASI · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Catherine Szyman
Median of the other named officers
$2,215,518
5 officers, excluding the chief executive
Latest say-on-pay support
=
April 29, 2025
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.

The Masimo brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Data as of October 22, 2026Latest filing (10-K): May 1, 2026
14 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Masimo brief$1,500Get the executive brief
Velarion Member, one year
295 figures on this page: 285 cited to the filing that reported them, 10 calculated from figures it prints. See the citations
Masimo does not file an annual proxy statement (DEF 14A). Its executive compensation is disclosed directly in its Form 10-K (Part III), which is the filing cited throughout this document.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive of record: Joe Kiani → Catherine Szyman
Say-on-pay support: 64.9% → 88.1% (23.2 points higher)
CEO pay ratio: 163:1 → 212:1 (30.1% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Masimo's chief executive and what were they paid?
Total compensation for Catherine Szyman, Chief Executive Officer, came to $19,797,140 in fiscal 2025.
What was Masimo's say-on-pay result?
For fiscal 2024, shareholders backed the say-on-pay proposal with 88.1% of votes cast for or against in favor at the meeting held April 29, 2025.
Which companies are in Masimo's peer group?
Companies named in the disclosed peer group include Align Technology, Inc., CONMED Corporation, DENTSPLY SIRONA, Inc., Dexcom, Inc. and Globus Medical, Inc., among others.
What is Masimo's chief executive pay ratio?
The company reported a chief executive pay ratio of 212:1 for fiscal 2025, against median employee compensation of $82,554.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Joe Kiani
Former Chief Executive Officer and Chairman of the Board
◇—◇◇◇—◇◇
Bilal Muhsin
Chief Operating Officer
◇—◇◇◇—◇◇
Micah Young
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Tom McClenahan
Executive Vice President, General Counsel and Corporate Secretary
◇—◇◇◇—◇◇
Tao Levy
Executive Vice President, Business Development
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Joe Kiani
Former Chief Executive Officer and Chairman of the Board
◇—◇◇——◇◇
Bilal Muhsin
Chief Operating Officer
◇—◇◇——◇◇
Micah Young
Executive Vice President and Chief Financial Officer
◇—◇◇——◇◇
Tom McClenahan
Executive Vice President, General Counsel and Corporate Secretary
◇—◇◇——◇◇
Tao Levy
Executive Vice President, Business Development
◇—◇◇——◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Joe Kiani
Former Chief Executive Officer and Chairman of the Board
Departed during or after this year
◇—◇◇——◇◇
Bilal Muhsin
Chief Operating Officer
◇—◇◇◇—◇◇
Micah Young
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Tom McClenahan
Executive Vice President, General Counsel and Corporate Secretary
◇—◇◇——◇◇
Blair Tripodi
Chief Operating Officer, Consumer Division
◇—◇◇◇—◇◇
Michelle Brennan
Former Interim Chief Executive Officer
Departed during or after this year
Served on an interim basis
◇—◇———◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Catherine Szyman
Chief Executive Officer
◇—◇◇◇—◇◇
Micah Young
Executive Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Charles Dadswell
Executive Vice President, General Counsel and Corporate Secretary
◇—◇—◇—◇◇
Greg Meehan
Chief Commercial Officer
◇—◇◇◇—◇◇
Anand Sampath
Executive Vice President, Operations
◇—◇—◇—◇◇
Michelle Brennan
Former Interim Chief Executive Officer
Departed during or after this year
◇◇————◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Anand SampathRSU◇——◇——◇
Catherine SzymanRSU◇——◇——◇
Catherine SzymanRSU◇——◇——◇
Catherine SzymanPSU◇◇◇—◇—◇
Catherine SzymanPSU◇◇◇—◇—◇
Catherine SzymanOPTION◇——◇—◇◇
Charles DadswellRSU◇——◇——◇
Greg MeehanRSU◇——◇——◇
Greg MeehanPSU◇◇◇—◇—◇
Greg MeehanOPTION◇——◇—◇◇
Micah YoungPSU◇◇◇—◇—◇
Micah YoungRSU◇——◇——◇
Micah YoungOPTION◇——◇—◇◇
Michelle BrennanRSU◇——◇——◇
Michelle BrennanRSU◇——◇——◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Micah YoungPSU◇◇——
PSU◇◇——
Option◇—◇3/1/2034
PSU◇◇——
RSU◇◇——
Option◇—◇2/22/2032
Option◇—◇3/11/2035
RSU◇◇——
Option◇—◇2/26/2031
Option◇—◇3/2/2033
Michelle BrennanRSU◇◇——
RSU◇◇——
RSU◇◇——
Anand SampathOption◇—◇2/26/2031
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/22/2032
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Catherine Szyman
Chief Executive Officer · Offer letter · dated January 17, 2025
Severance multiple◇
Change-in-control multiple◇
Equity acceleration on change in control◇
Benefits continuation on change in control◇
Benefits continuation◇
Non-solicit period◇
Clawback◇
Michelle Brennan
Former Interim Chief Executive Officer · Terms as described in the company’s compensation discussion · citing a 2025 filing
Severance base◇
Severance cash amount◇
Change-in-control base◇
Equity acceleration on change in control◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Quentin Koffey
◇◇———◇◇
Darlene Solomon
◇◇————◇
William Jellison
◇◇————◇
Tim Scannell
◇◇————◇
Wendy Lane
◇◇————◇
Robert Chapek
◇—————◇
Craig Reynolds
◇—————◇
Michelle Brennan and Catherine Szyman served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as restricted stock units.
Stock ownership guideline: Oversee and determine compliance with our stock ownership guidelines;

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Align Technology, Inc. ALGN
  • CONMED Corporation CNMD
  • DENTSPLY SIRONA, Inc. XRAY
  • Dexcom, Inc. DXCM
  • Globus Medical, Inc. GMED
  • Haemonetics Corp. HAE
  • Hologic, Inc. HOLX
  • ICU Medical, Inc. ICUI
  • Insulet Corporation PODD
  • Integer Holdings Corporation ITGR
  • LivaNova PLC LIVN
  • Merit Medical Systems, Inc MMSI
  • Penumbra, Inc. PEN
  • QuidelOrtho Corporation QDEL
  • Teleflex, Inc. TFX
  • The Cooper Companies, Inc. COO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2024April 29, 2025=◇◇◇
2023September 19, 2024=◇◇◇
2022June 26, 2023=◇◇◇
2021May 26, 2022=◇◇◇
2020May 27, 2021=◇◇◇
2019May 29, 2020=◇◇◇
2018May 30, 2019=◇◇◇
2017May 31, 2018=◇◇◇
2016June 1, 2017=◇◇◇
2015April 20, 2016=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Catherine Szyman (Chief Executive Officer), FY2025 total compensation $19,797,140 (base salary $850,048) [exec_comp, SEC accession 0001104659-26-054180, filed 2026-05-01]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Masimo files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Masimo disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Masimo sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Masimo's disclosed peer group is defensible, who names Masimo back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
295 figures on this page: 285 cited to the filing that reported them, 10 calculated from figures it prints.
285 cited to the filing
10 calculated from the filing

Documents cited

  1. 0001104659-26-054180
  2. 0001104659-25-042485
    Proposal No. 3 : To provide an advisory vote to approve the compensation of the Company’s named executive officers.
  3. 0001104659-25-027887
    Compensation Discussion and Analysis · Summary Compensation Table
  4. 0000937556-25-000007
    EX-10.1
  5. 0000937556-24-000085
    Proposal No. 3 : To provide an advisory vote to approve the compensation of the Company’s named executive officers.
  6. 0001213900-24-053125
    Summary Compensation Table
  7. 0000937556-23-000172
    Item 5.07 Submission of Matters to a Vote of Security Holders
  8. 0000937556-22-000107
    Item 5.07 Submission of Matters to a Vote of Security Holders
  9. 0000937556-21-000105
    Item 5.07 Submission of Matters to a Vote of Security Holders
  10. 0000937556-20-000119
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0000937556-19-000112
  12. 0000937556-18-000102
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0000937556-17-000132
    Item 5.07 Submission of Matters to a Vote of Security Holders
  14. 0000937556-16-000263
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Masimo executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/MASI (accessed 2026).
Short form: data: Velarion

The Masimo brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
14 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Masimo and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

MedTech & Diagnostics rankings

Peers Masimo discloses

The companies named in MASI's own disclosed peer group.

Terms on this page

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy